Oxford Finance closed a term loan and revolving line of credit to ReMed, a provider of rehab services to patients with post-acute acquired brain injuries. ReMed will use the proceeds for working capital purposes and to partially finance an acquisition.
Melinta Therapeutics entered into a restructuring support agreement with the lenders under its senior credit facility, Deerfield Private Design Fund III, L.P. and Deerfield Private Design Fund IV.
Aralex Pharmaceuticals’ U.S. and Ireland-based subsidiaries, as well as the company’s Canadian debtors, filed voluntary petitions under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the Southern District of New York.
Endologix entered into an agreement with Deerfield Management, a healthcare investment organization, to receive up to $170 million in funding through a $120 million six-year secured term loan and a $50 million three-year secured asset-based revolving line of credit.
Flamel Technologies said it has completed a $15 million debt financing with Deerfield Management, a current Flamel shareholder.